Ken Griffin Atri Cure, Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $73,224 - $106,200	3,600 Added 100.0%	7,200 $201,000
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $9,930 - $14,545	-500 Reduced 12.2%	3,600 $81,000
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $67,704 - $90,672	2,400 Added 141.18%	4,100 $124,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $56,083 - $73,525	1,700 New	1,700 $60,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $12,132 - $14,880	300 New	300 $14,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.72B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.